Can hepatitis C virus antigen testing replace ribonucleic acid polymearse chain reaction analysis for detecting hepatitis C virus? A systematic review

Open Forum Infectious Diseases

Volumn 4, Issue 2, 2017, Pages

  Khan, Harun ^a   Hill, Andrew ^b   Main, Janice ^a   Brown, Ashley ^a   Cooke, Graham ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

HCV antigen; HCV diagnostics; HCV RNA

Indexed keywords

HEPATITIS C ANTIGEN;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEPATITIS C; HEPATITIS C VIRUS ANTIGEN TEST; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 85029782786     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw252     Document Type: Review

References (44)

1. Cooke GS, Hill AM. Diagnostics for resource-limited settings in the era of interferon-free HCV therapy. J Viral Hepat 2015; 22:459-60
2. UNITAID. Hepatitis C-Diagnostics Technology Landscape. Available at: http:// unitaid.org/images/marketdynamics/publications/UNITAID-HCV_Diagnostic_ Landscape-1st_edition.pdf. Accessed 15 August 2016
3. PRISMA. PRISMA Statement. Available at: http://www.prisma-statement.org/ PRISMAStatement/ Accessed 15 August 2016
4. Moses L, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12:1293-316
5. Whiting P, Rutjes A, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155:529-36
6. Moscato G, Giannelli G, Grandi B, et al. Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C. Intervirology 2011; 54:61-5
7. Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett 2006; 27:861-74
8. Takada N, Takase S, Takada A, Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993; 17:277-83
9. Okazaki K, Nishiyama Y. Fundamental evaluation of HCV core antigen method comparison with Cobas Amplicor HCV monitor v2.0 (high range method). Rinsho Byori 2008; 56:95-100
10. Ross R, Viazov S, Salloum S. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J Clin Microbiol 2010; 48:1161-8
11. Miedouge M, Saune K, Kamar N, et al. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 2010; 48:18-21
12. Seiskari T, Horsti J, Aittoniemi J. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite antibody test result. J Clin Virol 2011; 51:90-1
13. Kesli R, Polat H, Terzi Y, et al. Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming. J Clin Microbiol 2011; 49:4089-93
14. Reddy A. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol 2006; 24:55-7
15. Peterson J, Green G, Iida K, et al. Detection of hepatitis C core antigen in the antibody negative 'window'phase of hepatitis C infection. Vox Sang 2000; 78:80-5
16. Bouvier-Alias M, Patel K, Dahari H, et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002; 36:211-8
17. Aoyagi K, Ohue C, Iida K, Kimura T. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999; 37:1802-8
18. Lorenzo J, Castro A, Aguilera A. Total HCV core antigen assay: a new marker of HCV viremia and its application during treatment of chronic hepatitis C. J Virol Methods 2004; 120:173-7
19. Hill AM, Roberts T, Amorosoa V, et al. Can HCV antigen testing replace HCV RNA PCR analysis, for diagnosis and monitoring of treatment for hepatitis C? In: AASLD: Diagnostics and NaturaL History; 2016; USA
20. Massaguer A, Forns X, Costa J. Performance of hepatitis C virus core antigen immunoassay in monitoring viral load after liver transplantation. Transplantation 2005; 79:1441-4
21. Graham C, Swan T. A path to eradication of hepatitis C in low-and middle-income countries. Antiviral Res 2015; 119:89-96
22. Cable R, Lelie N, Bird A. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Vox Sang 2013; 104:93-9
23. Kamili S, Drobeniuc J. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 2012; 55(Suppl 1):S43-8
24. UNITAID. Hepatitis C medicine: Technology and market landscape-update. Switzerland: UNITAID; 2015. Available at: http://www.unitaid.eu/images/marketdynamics/ publications/Hepatitis_C_Medicines_Technology_and_Market_ Landscape__Update.pdf. Accessed 15 August 2016
25. Roberts T, Bygrave H. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc 2012; 15:17324
26. Bennett S, Gunson R. Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol 2012; 54:106-9
27. Tuaillon E, Mondain A, Meroueh F. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 2010; 51:752-8
28. Greenman J, Roberts T. Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review. J Viral Hepat 2015; 22:353-61
29. Ergünay K, Sener B, Alp A. Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting. Diagn Microbiol Infect Dis 2011; 70:486-91
30. Cavoli GL, Zagarrigo C, Schillaci O, et al. Hepatitis C virus core antigen test in monitoring of dialysis patients. Hepat Res Treat 2012; 2012:832021
31. Mederacke I, Wedemeyer H, Ciesek S, et al. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J Clin Virol 2009; 46:210-5
32. Mederacke I, Potthoff A, Meyer-Olson D, et al. HCV core antigen testing in HIVand HBV-coinfected patients, and in HCV-infected patients on hemodialysis. J Clin Virol 2012; 53:110-5
33. Mixson-Hayden T, Dawson G, Teshale E, et al. Performance of ARCHITECT HCV core antigen test with specimens from the US plasma donors and injecting drug users. J Clin Virol 2015; 66:15-8
34. Park Y, Lee J, Kim B, et al. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol 2010; 48:2253-6
35. Garbuglia A, Monachetti A, Galli C, et al. HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes. BMC Infect Dis 2014; 14:222
36. Cress well F, Shaw S, Hughes D, et al. Hepatitis C antigen testing: a reliable alternative for diagnosing acute hepatitis C infection. In: BHIVA: HIV Medicine; 2014; UK
37. Schüttler C, Thomas C, Discher T, et al. Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera. J Clin Microbiol 2004; 42:1977-81
38. Alzahrani A. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. J Med Virol 2008; 80:603-6
39. Netski DM, Wang XH, Mehta SH, et al. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users. J Clin Microbiol 2004; 42:1631-6
40. Hayashi K, Hasuike S, Kusumoto K, et al. Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population. J Viral Hepat 2005; 12:106-10
41. Valcavi P, Medici MC, Casula F, et al. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. J Med Virol 2004; 73:397-403
42. Gaudy C, Thevenas C, Tichet J, et al. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J Clin Microbiol 2005; 43:1722-6
43. Soffredini R, Rumi MG, Parravicini ML, et al. Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy. Am J Gastroenterol 2004; 99:1738-43
44. Buket CA, Ayse A, Selçuk K, et al. Comparison of HCV core antigen and anti-HCV with HCV RNA results. Afr Health Sci 2014; 14:816-20